"Vi er et ideelt lokalsykehus i Oslo for innbyggerne i vestlige bydeler. Ambisjonen er å være et foretrukket lokalsykehus. Vi har driftsavtale med Helse Sør-Øst innen medisin, kirurgi, revmatologi og psykisk helsevern og tverrfaglig spesialisert rusbehandling. Vi har vi region- og landsfunksjoner på flere områder og har et stort forsknings- og innovasjonsmiljø. Sykehuset har ca 1700 ansatte og ligger i nærheten av Majorstuen med alt av kollektiv- og servicetilbud."

During the past decade, Diakonhjemmet Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diakonhjemmet Hospital" #1 sponsor was "Diakonhjemmet Hospital" with 20 trials, followed by "Oslo University Hospital" with 6 trials sponsored, "Oslo Metropolitan University" with 2 trials sponsored, "F.P.J.G. Lafeber" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diakonhjemmet Hospital" #1 collaborator was "Diakonhjemmet Hospital" with 7 trials as a collaborator, "Oslo University Hospital" with 4 trials as a collaborator, "South-Eastern Norway Regional Health Authority" with 3 trials as a collaborator, "The Norwegian Rheumatism Association" with 3 trials as a collaborator and "University Hospital of North Norway" with 3 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Diakonhjemmet Hospital" are "Rheumatoid Arthritis" (8 trials), "Psoriatic Arthritis" (4 trials), "Spondyloarthritis" (4 trials), "Ulcerative Colitis" (3 trials) and "Ankylosing Spondylitis" (2 trials). Many other conditions were trialed in "Diakonhjemmet Hospital" in a lesser frequency.

Most popular intervention types in "Diakonhjemmet Hospital" are "Other" (12 trials), "Drug" (8 trials), "Behavioral" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Exercise" (3 trials), "Placebo" (3 trials), "Remote monitoring" (2 trials), "50 mg AP1189" (1 trials) and "AP1189" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diakonhjemmet Hospital" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Diakonhjemmet Hospital". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 18 completed trials in Diakonhjemmet Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Diakonhjemmet Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 17 trials that are defined as “Not Applicable".

Diakonhjemmet Hospital has several departments that took part in Clinical trials: "Department of Rheumatology, Diakonhjemmet Hospital" - 6 trials